Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CRHR1 | P34998 | 1/20 | 0.74 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.74 |
| ▸ | CALCR | P30988 | 4/20 | 0.72 |
| ▸ | HCRTR1 | O43613 | 1/20 | 0.69 |
| ▸ | HCRTR2 | O43614 | 1/20 | 0.69 |
| ▸ | F2 | P00734 | 4/20 | 0.69 |
| ▸ | NPY2R | P49146 | 7/20 | 0.66 |
| ▸ | NPY4R | P50391 | 7/20 | 0.66 |
| ▸ | NPY5R | Q15761 | 7/20 | 0.66 |
| ▸ | NPY1R | P25929 | 5/20 | 0.66 |
| ▸ | CCKBR | P32239 | 2/20 | 0.64 |
| ▸ | GLP1R | P43220 | 2/20 | 0.64 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31362091 | 0.97 | CRHR1 (0.69) | CRHR1CRHR2CALCRHCRTR1HCRTR2 | |
| Neuropeptide Y(Npy) SCHEMBL29557110 | 0.95 | HCRTR1 (0.73) | CRHR1CRHR2CALCRHCRTR1HCRTR2 | |
| SCHEMBL29496288 | 0.94 | NPY2R (0.74) | CRHR1CRHR2CALCRNPY2RNPY4R | |
| SCHEMBL29440046 | 0.93 | CRHR1 (0.77) | CRHR1CRHR2CALCRHCRTR1HCRTR2 | |
| SCHEMBL29496391 | 0.91 | NPY2R (0.72) | CALCRNPY2RNPY4RNPY5RNPY1R | |
| SCHEMBL29379306 | 0.91 | F2 (0.78) | CRHR1CRHR2CALCRHCRTR1HCRTR2 | |
| Neuropeptide-Y SCHEMBL31042464 | 0.91 | NPY2R (0.73) | CRHR1CRHR2CALCRHCRTR1HCRTR2 | |
| SCHEMBL13248707 | 0.90 | NPY2R (0.80) | CALCRNPY2RNPY4RNPY5RNPY1R | |
| Human Neuropeptide Y SCHEMBL29523348 | 0.89 | CALCR (0.72) | CRHR1CRHR2CALCRNPY2RNPY4R | |
| SCHEMBL29376776 | 0.89 | NPY2R (0.82) | CRHR1CRHR2CALCRNPY2RNPY4R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2736 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-121202992-B | Novel long-acting Amylin receptor agonist and application thereof | Hangzhou Nuo Ao Biopharmaceutical Technology Co.,Ltd. (CN) | 2026-05-26 | — | — | CN | claimed |
| WO-2026106127-A1 | LACTICASEIBACILLUS PARACASEI HP7 USEFUL FOR GASTROINTESTINAL HEALTH WITH PREVENTIVE OR ALLEVIATIVE EFFICACY FOR FUNCTIONAL DYSPEPSIA AND USES THEREOF | 주식회사 에치와이 | 2026-05-21 | — | — | WO | claimed |
| CN-122036890-A | Procambrus clarkii oocyte targeting peptide VN_P, and design and screening method and application thereof | 浙江省农业科学院 | 2026-05-15 | — | — | CN | claimed |
| WO-2026099249-A1 | MODIFIED AND UNMODIFIED PEPTIDYLGLYCINE ALPHA-AMIDATING MONOOXYGENASE (PAM) FOR USE IN SUBJECTS HAVING INCREASED AMYLOID-BETA AND/OR PHOSPHO-TAU-PROTEIN LOAD AND/OR NEUROINFLAMMATION | PAM THERAGNOSTICS GMBH (DE) | 2026-05-15 | — | — | WO | claimed |
| US-20260124148-A1 | POLYPEPTIDE FORMULATIONS FOR ORAL DELIVERY | BHAMIS RES LABORATORY PVT LTD (IN) | 2026-05-07 | — | — | US | claimed |
| WO-2026088074-A1 | DIETARY FIBER COMPOSITION AND A PROCESS FOR ITS PREPARATION | AKAY NATURAL INGREDIENTS PRIVATE LIMITED (IN) | 2026-04-30 | — | — | WO | claimed |
| EP-4074729-B1 | AMYLIN ANALOGUES | ZEALAND PHARMA AS (DK) | 2026-04-15 | — | — | EP | claimed |
| EP-4271674-B9 | CARBOXY-BENZIMIDAZOLE GLP-1R MODULATING COMPOUNDS | GILEAD SCIENCES INC (US) | 2026-03-11 | — | — | EP | claimed |
| US-12570642-B2 | GLP-IR modulating compounds | GILEAD SCIENCES, INC. (US) | 2026-03-10 | — | — | US | claimed |
| EP-4694699-A2 | COMPOSITIONS AND METHODS OF CONTROLLING MAMMALIAN SATIETY | VitaKey Inc. (US) | 2026-02-18 | — | — | EP | claimed |
| US-20220133811-A1 | AKKERMANSIA MUCINIPHILA EB-AMDK27 STRAIN AND USE THEREOF | ENTEROBIOME INC. (KR) | 2022-05-05 | — | — | US | claimed |
| US-20220127325-A1 | GLUCAGON DERIVATIVE AND A COMPOSITION COMPRISING A LONG ACTING CONJUGATE OF THE SAME | HANMI PHARM. CO., LTD. (KR) | 2022-04-28 | — | — | US | claimed |
| EP-3988580-A2 | HYDROGEL INCLUSION COMPLEX CONTAINING BIOACTIVE SUBSTANCE BOUND TO TEMPERATURE-SENSITIVE POLYPHOSPHAZENE BY HOST-GUEST INTERACTION THROUGH BETA-CYCLODEXTRIN, AND USE THEREOF | Korea Institute of Science and Technology (KR) | 2022-04-27 | — | — | EP | claimed |
| CN-114269391-A | Hydrogel inclusion complexes comprising physiologically active substances bound to thermosensitive poly (phosphazene) through host-guest interactions using beta-cyclodextrin and uses thereof | 韩国科学技术研究院 | 2022-04-01 | — | — | CN | claimed |
| WO-2022058432-A1 | PHARMACEUTICAL COMPOSITION FOR ALLERGEN SPECIFIC IMMUNOTHERAPY | Hôpitaux Universitaires de Genève (CH) | 2022-03-24 | — | — | WO | claimed |
| US-20220073583-A1 | ACYLATED GLUCAGON ANALOGUES | ZEALAND PHARMA A/S (DK) | 2022-03-10 | — | — | US | claimed |
| CN-114127105-A | Anti-metallothionein antibodies and uses thereof | 康涅狄格大学 | 2022-03-01 | — | — | CN | claimed |
| US-11261227-B2 | Glucagon derivative and a composition comprising a long acting conjugate of the same | HANMI PHARM. CO., LTD. (KR) | 2022-03-01 | — | — | US | claimed |
| US-20220048868-A1 | Microcrystalline Diketopiperazine Compositions and Methods | WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL AGENT | 2022-02-17 | — | — | US | claimed |
| US-11241549-B2 | Dry powder inhaler and system for drug delivery | MANNKIND CORPORATION (US) | 2022-02-08 | — | — | US | claimed |